List of diseases involving glycan related genes. The information of each database of Glyco-Disease Genes Database (GDGDB) and Alliance of Genome Resources is integrated into one list.
Source | Last Updated |
---|---|
Alliance of Genome Resources | October 9, 2024 |
Glyco-Disease Genes Database (GDGDB) | January 25, 2017 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Organism | Source |
---|---|---|---|---|---|
DOID:0112182 |
|
Mus musculus (house mouse) | |||
DOID:3883 |
|
Mus musculus (house mouse) | |||
DOID:0050861 |
|
Mus musculus (house mouse) | |||
DOID:1909 |
|
Mus musculus (house mouse) | |||
DOID:234 |
|
Mus musculus (house mouse) | |||
DOID:1324 |
|
|
|
Mus musculus (house mouse) | |
DOID:3717 |
|
Mus musculus (house mouse) | |||
DOID:0080556 |
|
Xenopus laevis (African clawed frog) | |||
DOID:0110158 |
|
Xenopus laevis (African clawed frog) | |||
DOID:0110200 |
|
Xenopus laevis (African clawed frog) | |||
DOID:0110157 |
|
Xenopus laevis (African clawed frog) | |||
DOID:10595 |
|
Xenopus laevis (African clawed frog) | |||
DOID:0050540 |
|
Xenopus laevis (African clawed frog) | |||
DOID:0110152 |
|
Xenopus laevis (African clawed frog) | |||
DOID:2043 |
|
Xenopus laevis (African clawed frog) | |||
DOID:4492 |
|
Xenopus laevis (African clawed frog) | |||
DOID:14069 |
|
Xenopus laevis (African clawed frog) | |||
DOID:1273 |
|
Xenopus laevis (African clawed frog) | |||
DOID:6432 |
|
Xenopus laevis (African clawed frog) | |||
DOID:11984 |
|
Xenopus laevis (African clawed frog) | |||
DOID:3587 |
|
Xenopus laevis (African clawed frog) | |||
DOID:8947 |
|
Xenopus laevis (African clawed frog) | |||
DOID:0080600 |
|
Xenopus laevis (African clawed frog) | |||
DOID:2945 |
|
Xenopus laevis (African clawed frog) | |||
DOID:6000 |
|
Xenopus laevis (African clawed frog) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024